Listen Now

Show NotesWhat it’s like to be part of an APP Critical Care Fellowship Program? Vincent DeRienzo, Physician Associate and Assistant Director of the APP Critical Care Medicine Fellowship Program at the Univ of Rochester walks us thought their fellowship program development, processes, successes and lessons they’ve learned along the way.NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.GuestVincent DeRienzoVincent DeRienzo graduated from the Daemen College Physician Assistant program. Vincent does research in Critical Care Medicine, Advanced Practice Provider Education, Psychiatry, Emergency Medicine and Health Psychology. His most recent publication is 'Depression symptomology groups among middle and older adult emergency department patients'. HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers. In addition to her work with APAPP, Corinne was one of the first ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs and serves on Networks, has participated on the Executive Programing Committee, and is on the Editorial Board of Chest Physician Magazine. Additionally, Corinne serves on the American Board of Internal Medicine’s Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/limitations-of-hyperkalemia-treatment-8849Featuring faculty George Bakris, MD, moderated by Gregg Sherman, MD.SummaryHyperkalemia is a common condition in certain patient populations and can increase risks for hospitalizations and mortality, especially when potassium levels are not monitored appropriately. Furthermore, incorporating traditional treatment approaches for managing hyperkalemia have significant challenges, especially in high-risk patients.In this first of two podcast episodes, Dr. George Bakris and Dr. Gregg Sherman discuss the causes, risk factors, and consequences of hyperkalemia, as well as traditional treatment approaches and their limitations. This podcast was recorded and is being used with the permission of the presenters.This CME/CE podcast is available for credit on myCME. Click the button on the right to listen now.Learning ObjectivesUpon completion of this activity, learners should be able to: Recognize the chronic nature of hyperkalemia and its causes, risk factors, and consequences Discuss the management of hyperkalemia, including the challenges of dietary and traditional treatment approaches This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology). Summary of Individual DisclosuresGeorge Bakris: has disclosed the following financial relationships: Consultant: Bayer (Diabetic Kidney Disease), KBP BioSciences (Hypertension), Ionis (Hypertension), Alnylam (Hypertension), AstraZeneca (Hyperkalemia), Novo Nordisk (Diabetic Kidney Disease), Janssen (Hypertension), inRegen (Kidney Disease) Contracted Research: KBP BioSciences (Hypertension) Angela Golden has disclosed the following financial relationships: Consultant: SetPoint (Obesity), WW (Obesity) Advisor: Currax (Obesity), Genesis (Obesity), Lilly (Obesity), Novo Nordisk (Obesity), (Obesity), Acela (Hypothyroidism) Speaker: Currax, Novo Nordisk (Obesity) Receipt of Royalty: Amazon (fiction books), Springer (obesity book) Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial SupportThis educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/management-of-hyperkalemia-in-high-risk-patients-8850Featuring faculty George Bakris, MD, moderated by Gregg Sherman, MD.SummaryHyperkalemia is a common condition in certain patient populations and can increase risks for hospitalizations and mortality. The limitations of traditional treatment approaches make management of high-risk patients challenging, particularly in those with chronic kidney disease (CKD), heart failure (HF), and hypertension. However, new and emerging treatment options are available for the management of hyperkalemia and may improve outcomes in these patients.In this second of two podcast episodes, Dr. George Bakris and Dr. Gregg Sherman discuss new and emerging treatment options for the management of hyperkalemia, and how to incorporate these therapies most effectively for patients with CKD, HF, and hypertension. This podcast was recorded and is being used with the permission of the presenters.This CME/CE podcast is available for credit on myCME. Click the button on the right to listen now.Learning ObjectivesUpon completion of this activity, learners should be able to: Incorporate current and emerging therapies into the management of hyperkalemia in patients with CKD, HF, and hypertension based on recent clinical trial data This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology). Summary of Individual DisclosuresGeorge Bakris: has disclosed the following financial relationships: Consultant: Bayer (Diabetic Kidney Disease), KBP BioSciences (Hypertension), Ionis (Hypertension), Alnylam (Hypertension), AstraZeneca (Hyperkalemia), Novo Nordisk (Diabetic Kidney Disease), Janssen (Hypertension), inRegen (Kidney Disease) Contracted Research: KBP BioSciences (Hypertension) Angela Golden has disclosed the following financial relationships: Consultant: SetPoint (Obesity), WW (Obesity) Advisor: Currax (Obesity), Genesis (Obesity), Lilly (Obesity), Novo Nordisk (Obesity), (Obesity), Acela (Hypothyroidism) Speaker: Currax, Novo Nordisk (Obesity) Receipt of Royalty: Amazon (fiction books), Springer (obesity book) Faculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial SupportThis educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Show Notes PA Anne Cartwright isn't called the "PAP Guru" for nothing. In this episode she will walk you through how to help your sleep apnea patients get compliant with CPAP therapy. Listen in and learn how to trouble shoot common CPAP roadblocks and how to set your patients up for success. Visit www.pulmapp.com for more sleep apnea content information.NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP).  APAPP is the first  association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of  patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com. GuestAnn Cartwright, MPAS, PA-CAnn Cartwright is currently working as a Physician Assistant/Instructor Division of Pulmonary, Critical Care, and Sleep Medicine at the University of Colorado School of Medicine. She completed her education at the University of New England. Her clinical interests are Sleep Medicine, Lung and Breathing, Obstructive Sleep Apnea, Respiratory system, Cardiovascular system, Nervous system, and Insomnia. HostCorinne R. Young, MSN, FNP-C, FCCPDirector of APP and Clinical Services, Colorado Springs Pulmonary ConsultantsPresident, APAPP, Colorado Springs, COCorinne Young is a Nurse Practitioner began working in the area of pulmonary disease in California in 2005. Since 2011, she has worked in a private pulmonary practice in Colorado Springs, Colorado. Involvement and the representation of advanced practice providers in the pulmonary world has been an important priority for Corinne.  To that end,  Corinne is the Founder and President of the Association of Pulmonary Advanced Practice Providers. In addition to her work with APAPP, Corinne is currently one of ten NPs nationwide to become a Fellow of the American College of Chest Physicians. She works closely with the American College of Chest Physicians CHEST programs, and serves on the Interprofessional Team Network, Clinical Research Network, and on the Executive Programing Committee. Additionally, Corinne serves on the American Board of Internal Medicine Pulmonary Disease Board.This Podcast episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: 1. Comparative Effectiveness of Digital Cognitive Behavioral Therapy vs Medication Therapy Among Patients With Insomnia – JAMA Network Open Guest:Aaron Sutton Clinical Assistant Professor of Family and Community Medicine at Thomas Jefferson University and the Behavioral Health Faculty at the Family Medicine Residency program at Abington Jefferson Health Chief Wellness Officer for graduate medical education at Abington Jefferson Health, Abington, PA. 2. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta- analysis of Individual Participant Data From 3 Randomized Clinical Trials Guest: Anastassios G Pittas, MD,  Professor of Internal MedicineTufts School of Medicine Boston, MA3. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis Guest: Gabriella Petrongolo, DO, Second Year ResidentFamily Medicine ResidencyJefferson Health-Abington, Abington, PA 4. Dietary sugar consumption and health: umbrella review Guest: Richard Potter, MD, First Year Resident, Family Medicine ResidencyJefferson Health-Abington, PA Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit.  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Welcome to the NACE Journal Club, where each month we discuss some of the most important recent articles to come out in the medical literature.  This month Dr. Skolnik and guests will be discussing:Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients The New England Journal of Medicine March 4, 2023Dr. James Underberg who is a Clinical Assistant Professor of Medicinein the Division of General Internal Medicine at NYU Medical School, a boardcertified lipidologist and a Past president of the National Lipid Association. Non-occupational physical activity and risk of cardiovascular disease, cancer, and mortality outcomes: a dose–response meta-analysis of large prospective studies - British Journal of Sports MedicineDr. Bill Callahan who is a Associate Director in the family medicineresidency program at Jefferson Health – Abington.Lecanemab in Early Alzheimer’s Disease - New England Journal of MedicineDr. Meera Shah who is an Associate Director in the family medicine residency program at Jefferson Health – Abington and director of the geriatric curriculumTwo-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort studyDr. Byce Eng who is a second year resident in the family medicine residency program at Jefferson Health – Abington. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, is a new series of episodes that provide review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications: Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture Major Extremity Trauma Research Consortium (METRC), N Engl J Med 2023; 388:203-213Guest: Marissa Norden, DO,  2nd year resident Jefferson Health Abington Long-term Weight Training and Mortality in U.S. Male Health Professionals With and Without Type 2 Diabetes Dong Hoon Lee et.al.;Diabetes Care 2023;46(1):138–148Guest: Matt Rubin, MD, attending physician at Main Line Health  Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low- Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Ann Intern Med. 2023 Jan;176(1):I18. doi: 10.7326/P22-0022. Epub 2022 Dec 13. Guest: Gabriella Petrongolo, DO, 2nd year resident Jefferson Health Abington Associations of Physical Inactivity and COVID-19 Outcomes - American Journal of Preventive Medicine  Young DR, Sallis JF, Baecker A, Cohen DA, Nau CL, Smith GN, Sallis RE.;Am J Prev Med. 2022 Dec 10:S0749-3797(22)00526-8. doi: 10.1016/j.amepre.2022.10.007. Epub ahead of print.            Guest: Alex Fierstein, DO, 3rd year resident Jefferson Health AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode, Dr. Neil Skolnik and Dr. Leana S. Wen discuss addressing unmet needs in the management of COVID-19. They will discuss the importance of layering mitigation and protection strategies for those who are most at risk, along with the role of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis with emphasis on patients who are immunocompromised and may not respond to vaccination, in light of evolving variants. This episode is part three of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.   Funds for this activity have been provided by AstraZeneca. This activity does not offer CME/CE credit Faculty: Neil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PA Leana S. Wen, MD, MScProfessor, Health Policy and ManagementDistinguished Fellow, Fitzhugh Mullan Institute forHealth Workforce EquityGeorge Washington University School of Public Health Washington, DC Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

The NACE Journal Club with Dr. Neil Skolnik, is a new series of episodes that provide review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. The protective effect of exercise against Covid infection and hospitalization in individuals vaccinated against covid, Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case–control study. Collie S, et al. Br J Sports Med2022;0:1–7. doi:10.1136/bjsports-2022-105734Guest: Connie Jiang, MD is chief resident in the family medicine residency at Jefferson-Abington Health, Abington Hospital, Abington, PA2. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. Solomon, et.al. N Engl J Med 2022; 387:1089-1098DOI: 10.1056/NEJMoa2206286Guest: Orly Vardeny, Pharm.D is a BPS Board Certified clinical pharmacist with current research that focuses on novel therapies in the treatment of heart failure and the impact of influenza vaccination on heart disease. She has over 10 years of experience researching the effects of medications on cardiovascular conditions. Dr. Varney is a Core Investigator at the Center for Care Delivery and Outcomes Research, United States Department of Veterans Affairs, Associate Professor of Medicine, University of Minnesota Medical School, and Adjunct Faculty, University of Minnesota College of Pharmacy.3. Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. Hoge EA, et al, JAMA Psychiatry. 2023 Jan 1;80(1):13-21. doi: 10.1001/jamapsychiatry.2022.3679.Guest: Bridget Smith, MD is a second-year resident in the family medicine residency at Jefferson Health – Abington, Abington Hospital, Abington, PA  4. Empagliflozin in Patients with Chronic Kidney Disease. The EMPA-KIDNEY Collaborative Group, N Engl J Med 2023; 388:117-127DOI: 10.1056/NEJMoa2204233Guest: Katie McKormick, MD  is a second year resident in the family medicine residency at Jefferson Health – Abington, Abington Hospital, Abington, PAMedical Director and Host: Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode, Dr. Neil Skolnik and Dr. Myron J. Levine discuss the use of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis. They  explore the challenges and opportunities primary care clinicians and specialists  face identifying appropriate patients to receive this treatment, with emphasis on patients who are immunocompromised and may not respond to vaccination. This episode is part two of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.  This podcast episode is sponsored by AstraZeneca.  This activity does not offer CME/CE credit Faculty: Neil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PA Myron J. Levine, MDAssociate Director, Pediatric HIV ClinicProfessor, Pediatrics-Infectious DiseasesUniversity of Colorado Anschutz Medical Campus School of MedicineAurora, CO Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode, Dr. Neil Skolnik and Dr. Amy Clouse discuss the use of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis. They  explore the challenges and opportunities primary care clinicians and specialists  face identifying appropriate patients to receive this treatment, with emphasis on patients who are immunocompromised and may not respond to vaccination. This episode is part one of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.  This podcast episode is sponsored by AstraZeneca.  This activity does not offer CME/CE credit Faculty: Neil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PA Amy Clouse, MD, FAAFPClinical Associate Professor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PA Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this episode.  Ms. Ashlyn Smith, P.A., 2022 AAPA Physician Assistant of the Year, Endocrinology, answers questions about current topics in hyperthyroidism and clinical considerations for the diagnosis and treatment of patients with hyperthyroidism. This session was originally recorded live on November 5, 2022 at the NACE Emerging Challenges and Clinical Updates in Primary Care Virtual Symposium. This Episode does not offer CME/CE credit. FacultyAshlyn Smith, MMS, PA-CAdult Endocrine PAPresident, American Society of Endocrine Physician AssistantsAdjunct Assistant Professor, Midwestern University, Glendale, AZPhoenix, AZModeratorGregg Sherman, MDChief Medical OfficerNational Association for Continuing EducationPlantation, FL Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/considerations-in-the-approach-to-obesity-managementFeaturing speaker Robert Kushner, MD, moderated by Gregg Sherman, MD.Summary Obesity is a chronic disease, the care of which starts in the primary care office. However, it's an intricate diagnosis that can sometimes feel too big to take on in a primary care visit. In this podcast, Dr. Robert Kushner, an obesity management specialist, and NACE Chief Medical Officer and Family Physician, Dr. Gregg Sherman, discuss the disease of obesity, its diagnosis, and aspects of management that can make addressing obesity within your patients a little less daunting. This podcast was recorded and is being used with the permission of the presenters. Learning Objective Upon completion of this activity, learners should be able to: Recognize obesity as a chronic, relapsing disease with unique, distinct pathophysiology that contributes to adiposity, comorbidities, and complications. Develop individualized treatment plans for patients with obesity that incorporate evidence-based and clinical practice guidelines. This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.50 contact hours (which includes 0 hours of pharmacology).The "Considerations in the Approach to Obesity Management", offered has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for up to 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.This activity is part of the Obesity Management in Primary Care Training and Certificate Program provided by the National Association for Continuing Education (NACE) and the American Academy of Physician Associates (AAPA) in collaboration with The Obesity Society (TOS).Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships: Consultant: Novo Nordisk Advisor: Gelesis Biotechnology, Currax Pharmaceuticals, Novo Nordisk, Alfasigma, Acella Pharmaceuticals, Scynexis, Hisamitsu Pharmaceutical Speaker: Novo Nordisk, Acella Pharmaceuticals Receipt of Royalty: Springer Robert Kushner has disclosed the following financial relationships: Consultant: Eli Lilly Advisory Board: Novo Nordisk, WW Disclosure of Commercial SupportThis educational activity is supported by an independent educational grant from Novo Nordisk Inc. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/glp-1-ra-a-powerful-tool-for-risk-reduction-in-diabetesFeaturing speaker Javier Morales, MD, FACP, FACE, moderated by Gregg Sherman, MD.Summary Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of therapies used for the treatment of patients with type 2 diabetes (T2D). However, the role of GLP-1 RA therapy continues to evolve and expands beyond glycemic control for these patients, and includes cardiorenal protective effects. Recently updated clinical practice guidelines now recommend treatment with GLP-1 RA therapy that has demonstrated benefit in cardiovascular risk reduction in all patients with T2D. In this podcast episode, Dr. Javier Morales and Dr. Gregg Sherman discuss strategies for selecting optimal GLP-1 RA, the early initiation of GLP-1 RA therapy in appropriate patients, and improved adherence through adverse event management. This podcast was recorded and is being used with the permission of the presenters. Learning ObjectiveUpon completion of this activity, learners should be able to: Select GLP-1 RA therapy for early use in appropriate patients with T2DM, based on current guidelines, patient characteristics, and evolving data  Incorporate management strategies for the adverse gastrointestinal effects of GLP-1 RAs to improve patient adherence This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Summary of Individual Disclosures Angela Golden has disclosed the following financial relationships:  Consultant: Novo Nordisk Advisor: Gelesis Biotechnology, Currax Pharmaceuticals, Novo Nordisk, Alfasigma, Acella Pharmaceuticals, Scynexis, Hisamitsu Pharmaceutical Speaker: Novo Nordisk, Acella Pharmaceuticals Receipt of Royalty: Springer Javier Morales has disclosed the following financial relationships: Consultant/Advisor: Novo Nordisk, Lilly, Boehringer Ingelheim, Bayer, Intarcia Speaker/Independent Contractor: Novo Nordisk, Lilly, Boehringer Ingelheim, Bayer, Zealand Pharmaceuticals Contracted Research: Novo Nordisk This educational activity is supported by an independent educational grant from Novo Nordisk Inc. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/treating-iron-deficiency-anemia-what-you-need-to-know-nowFeaturing speakers Lee P. Shulman, MD, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, moderated by Gregg Sherman, MD.Summary As prevalent as IDA is in the population, how do you treat their anemia and replete iron stores? Sulfate, gluconate, or maltol? This discussion, between two respective experts in primary care and OB/GYN and our primary care moderator, continues and concludes our 2-part podcast series to answer that question. Oral and parenteral iron repletion, managing and mitigating side effects, and monitoring efficacy of treatment round out the discussion on the management of IDA. This podcast was recorded and is being used with the permission of the presenters. Learning Objective Upon completion of this activity, learners should be able to: Utilize an evidence-based, patient approach to management of iron deficiency that maximizes adherence to treatment Accurately assess iron stores in patients with anemia and those on iron replacement therapy. This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Summary of Individual Disclosures Angela Golden has disclosed the following financial relationships:  Consultant: Novo Nordisk Advisor: Gelesis Biotechnology, Currax Pharmaceuticals, Novo Nordisk, Alfasigma, Acella Pharmaceuticals, Scynexis, Hisamitsu Pharmaceutical Speaker: Novo Nordisk, Acella Pharmaceuticals Receipt of Royalty: Springer Lee Shulman has disclosed the following financial relationships: Consultant: Shield, Daiichi-Sankyo, Organon & Co., Mayne Pharma, Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Advisor: Shield, Organon & Co., Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Speaker: Shield, Daiichi-Sankyo, Mayne Pharm, Agile Member of Review Panel: Astellas Pharm Wendy Wright has disclosed the following financial relationships: Consultant: Moderna, Seqirus, Pfizer, Merck, Sanofi, GlaxoSmithKline, Bayer, Idorsia, Shield Therapeutics Speaker: AbbVie, Biohaven, Merck, Pfizer, and Sanofi This activity is supported by an educational grant from Shield Therapeutics. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/the-unmet-needs-of-iron-deficiency-screening-diagnosisFeaturing speakers Lee P. Shulman, MD, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, moderated by Gregg Sherman, MD.Summary Do you consider iron deficiency anemia (IDA) as much as you should in at-risk patients? A third of the US population will experience IDA in their lifetime, whether due to blood loss or nutritional deficiency. How do you determine which third of your patients have or are at risk for this condition? In this, the first of a 2-podcast series on IDA, experts in primary care and OB/GYN discuss with our primary care moderator the identification of patients who need screening for anemia and iron deficiency and how to screen and diagnose those patients. Hemoglobin, transferrin saturation, serum iron, ferritin! With so many options, how does a provider thoughtfully approach the workup of IDA? Tune in, and find out. This podcast was recorded and is being used with the permission of the presenters. Learning Objective Upon completion of this activity, learners should be able to: Recognize patients at risk for iron deficiency anemia Accurately assess iron stores in patients with anemia and those on iron replacement therapy This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Summary of Individual Disclosures Angela Golden has disclosed the following financial relationships:  Consultant: Novo Nordisk Advisor: Gelesis Biotechnology, Currax Pharmaceuticals, Novo Nordisk, Alfasigma, Acella Pharmaceuticals, Scynexis, Hisamitsu Pharmaceutical Speaker: Novo Nordisk, Acella Pharmaceuticals Receipt of Royalty: Springer Lee Shulman has disclosed the following financial relationships: Consultant: Shield, Daiichi-Sankyo, Organon & Co., Mayne Pharma, Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Advisor: Shield, Organon & Co., Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Speaker: Shield, Daiichi-Sankyo, Mayne Pharm, Agile Member of Review Panel: Astellas Pharm Wendy Wright has disclosed the following financial relationships: Consultant: Moderna, Seqirus, Pfizer, Merck, Sanofi, GlaxoSmithKline, Bayer, Idorsia, Shield Therapeutics Speaker: AbbVie, Biohaven, Merck, Pfizer, and Sanofi This activity is supported by an educational grant from Shield Therapeutics. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In Part three of the Second Anniversary Special, Dr. Skolnik interviews special guests, Chief Resident Dr Morgan Katz, and Resident Dr. Victoria Persampiere. Dr Katz and Dr. Persampiere, who share their experience of serving their entire medical residency during the pandemic, and answer audience questions. Dr Wen, Dr. Skolnik, the producers, and the entire NACE team offer special thanks to the COVIDD-19 Update  audience of over 100,000 health care workers and pandemic veterans who have attended these live virtual broadcasts and downloaded these podcast episodes .   In Dr Skolnik's words "You are who makes these updates come alive!"To view the full video episode (parts 1-3) of this podcast please visit https://vimeo.com/688026452/86459c5b78Faculty Co-Course Director and ModeratorNeil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PACo-Course Director and ModeratorLeana S. Wen, MD, MScProfessor, Health Policy and Management Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity George Washington University School of Public HealthWashington, DCGuest Faculty Morgan Katz, DOChief Resident, Family MedicineAbington-Jefferson HealthAbington, PAGuest Faculty Victoria Persampiere, DOAbington Family Medicine, PGY-2Abington, PA______Executive ProducerStephen R. WebberProduced by:Stephen R. Webber Sandy BihlmeyerJason JimmersonEleanor FrankeDirected By:Stephen R. WebberCreated by: Stephen R. Webber and Neil Skolnik, MDThis podcast was recorded on March 12, 2022.This podcast is not accredited for CME credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In part two of this second anniversary special episode, Dr. Neil Skolnik and Dr. Leana Wen provide the  up to the minute State of the  Pandemic report. Special thanks to our audience of dedicated clinician learners from Dr Wen, Dr. Skolnik, the producers, and the entire NACE team. In Dr Skolnik's words "You are what makes The NACE COVID-19 Update Come Alive!"To watch  the entire second Anniversary Special Episode please visit https://vimeo.com/688026452Faculty Co-Course Director and ModeratorNeil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PACo-Course Director and ModeratorLeana S. Wen, MD, MScProfessor, Health Policy and Management Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity George Washington University School of Public HealthWashington, DCExecutive ProducerStephen R. WebberProduced by:Stephen R. Webber Sandy BihlmeyerJason JimmersonEleanor FrankeDirected By:Stephen R. WebberCreated by: Stephen R. Webber and Neil Skolnik, MDThis podcast was recorded on March 12, 2022.This podcast is not accredited for CME credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Reflections,  part one of the second anniversary special episode, begins  with  a retrospective  compiled by the producers of the past 52 episodes to provide us all  with a moment to think about the path we have endured together over the past two years of the COVID-19 pandemic.  Following the retrospective, Dr. Leana Wen and Dr. Neil Skolnik reflect on their experience providing 52 evidence-based updates and answering attendee questions since Episode 1 on March 14, 2020. Dr Wen, Dr. Skolnik, the producers, and the entire NACE team offer special thanks to the COVIDD-19 Update  audience of over 100,000 health care workers and pandemic veterans who have attended these live virtual broadcasts and downloaded these podcast episodes .   In Dr Skolnik's words "You are who makes these updates come alive!"To view the full video episode (parts 1-3) of this podcast please visit https://vimeo.com/688026452/86459c5b78This podcast was recorded on March 12, 2022.This podcast is not accredited for CME credit.Faculty Co-Course Director and ModeratorNeil Skolnik, MDProfessor of Family and Community MedicineSidney Kimmel Medical CollegeThomas Jefferson UniversityAssociate DirectorFamily Medicine Residency ProgramAbington Jefferson HealthPhiladelphia, PACo-Course Director and ModeratorLeana S. Wen, MD, MScProfessor, Health Policy and Management Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity George Washington University School of Public HealthWashington, DCSpecial Guests in order of appearance:Reverend Dr. Robert L. BrashearSusan Fidler, MDMorgan Katz, DOWendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP Executive ProducerStephen R. WebberProduced by:Stephen R. Webber Sandy BihlmeyerJason JimmersonEleanor FrankeDirected By:Stephen R. WebberCreated by: Stephen R. Webber and Neil Skolnik, MDThis Podcast Was recorded on March 12, 2020This podcast is not available for CME Credit  Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Dr. Leana Wen and Dr. Chris Notte discuss the current state of the COVID-19 pandemic with specific emphasis on the approval of the first vaccine, testing, and answer attendee questions.  This segment was recorded on December 12,  2020, at the NACE Conversations in Primary Care broadcast.This podcast is not accredited for CME credit. FacultyLeana S. Wen, MD, MScVisiting Professor, Health Policy and ManagementDistinguished Fellow, Fitzhugh Mullan Institute for Health Workforce EquityGeorge Washington University School of Public HealthWashington, DCChristopher Notte, MDChief Medical OfficerAbington-Lansdale HospitalAsst. Chief Medical Information OfficerJefferson HealthClinical Asst. Professor, Dept. of Family &Community MedicineThomas Jefferson UniversityAbington, PA Please visit http://naceonline.com to engage in more live and on demand CME/CE content.